FNY Investment Advisers’s Terns Pharmaceuticals TERN Stock Holding History

FNY Investment Advisers’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-56,720	Closed	-$2.99M	–	1051
2026 Q1	$2.99M	Buy	56,720 +54,720	+2,736%	+$2.25M	1.31%	15
2025 Q4	$80K	Buy	+2,000	New	+$46.2K	0.02%	375

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's TERN Position: Q2 2026 in Review

FNY Investment Advisers sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 56,720 shares — an estimated $2.99M sold.

FNY Investment Advisers first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $2.99M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

FNY Investment Advisers reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
FNY Investment Advisers sold 56,720 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.99M.
FNY Investment Advisers first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
FNY Investment Advisers's Terns Pharmaceuticals position peaked at $2.99M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.